ORAI1 and breast carcinoma: Our results indicated that both Orai1 variants were highly expressed in the breast cancer MCF7 and MDA-MB-231 cell lines as compared to non-tumoral MCF10A cells (Figure 1h; p < 0.05; n = 6).